DE2327636A1 - Pharmazeutisches praeparat - Google Patents

Pharmazeutisches praeparat

Info

Publication number
DE2327636A1
DE2327636A1 DE19732327636 DE2327636A DE2327636A1 DE 2327636 A1 DE2327636 A1 DE 2327636A1 DE 19732327636 DE19732327636 DE 19732327636 DE 2327636 A DE2327636 A DE 2327636A DE 2327636 A1 DE2327636 A1 DE 2327636A1
Authority
DE
Germany
Prior art keywords
seryl
hydrazine
pharmaceutically acceptable
trihydroxybenzyl
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19732327636
Other languages
German (de)
English (en)
Inventor
Willy Dr Haefely
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE2327636A1 publication Critical patent/DE2327636A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19732327636 1972-06-30 1973-05-30 Pharmazeutisches praeparat Pending DE2327636A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH984672 1972-06-30

Publications (1)

Publication Number Publication Date
DE2327636A1 true DE2327636A1 (de) 1974-01-17

Family

ID=4356299

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19732327636 Pending DE2327636A1 (de) 1972-06-30 1973-05-30 Pharmazeutisches praeparat

Country Status (18)

Country Link
AT (1) AT338412B (xx)
AU (1) AU476456B2 (xx)
BE (1) BE801645A (xx)
CA (1) CA1015272A (xx)
DD (1) DD107592A5 (xx)
DE (1) DE2327636A1 (xx)
ES (1) ES416383A1 (xx)
FR (1) FR2190453B1 (xx)
GB (1) GB1369189A (xx)
HU (1) HU167292B (xx)
IE (1) IE37833B1 (xx)
IL (1) IL42317A (xx)
LU (1) LU67898A1 (xx)
NL (1) NL7308435A (xx)
PH (1) PH9584A (xx)
SE (1) SE407744B (xx)
SU (1) SU533323A3 (xx)
ZA (1) ZA733284B (xx)

Also Published As

Publication number Publication date
PH9584A (en) 1976-01-19
IE37833L (en) 1973-12-30
DD107592A5 (xx) 1974-08-12
CA1015272A (en) 1977-08-09
SU533323A3 (ru) 1976-10-25
AU476456B2 (en) 1976-09-23
ES416383A1 (es) 1976-02-16
HU167292B (xx) 1975-09-27
SE407744B (sv) 1979-04-23
AT338412B (de) 1977-08-25
AU5589773A (en) 1974-11-21
IL42317A0 (en) 1973-07-30
IE37833B1 (en) 1977-10-26
LU67898A1 (xx) 1975-04-11
FR2190453A1 (xx) 1974-02-01
GB1369189A (en) 1974-10-02
BE801645A (fr) 1974-01-02
ATA574273A (de) 1976-12-15
FR2190453B1 (xx) 1976-04-09
NL7308435A (xx) 1974-01-02
ZA733284B (en) 1974-03-27
IL42317A (en) 1976-04-30

Similar Documents

Publication Publication Date Title
DE2856393C2 (de) Arzneimittel zur Behandlung von Morbus Parkinson
DE4037708A1 (de) Appetitzuegler und verfahren zu seiner anwendung
DE60020501T3 (de) Trimetazidinhaltige Matrixtablette zur verlängerten Wirkstofffreisetzung nach oraler Gabe
DE19938825A1 (de) Wirkstoffkombination mit Clonidin
DE2513940A1 (de) Pharmazeutische zubereitung
EP0007597B1 (de) N-Niedrigalkylglycinamide und Sarkosinanhydrid sowie in Kombination mit bekannten tumorhemmenden Verbindungen vorliegendes Sarkosin zur Anwendung bei der Heilung von Tumoren sowie dieselben enthaltendes Mittel und Verfahren zu dessen Herstellung
EP0224810B1 (de) Antihypertensives Kombinationspräparat
EP0132595B1 (de) Tokolytisches Mittel
DE3011274C2 (de) Pharmazeutisches Präparat mit Strahlenschutzwirkung
DE2327636A1 (de) Pharmazeutisches praeparat
DE2513597B2 (de) L-5-hydroxytryptophan-l-glutamatmonohydrat, verfahren zu seiner herstellung und arzneimittel
DE2128730A1 (de) Mittel zur Kompensierung eines Dopaminmangels im Gehirn
DE2525064A1 (de) Arzneimittel und verfahren zu seiner herstellung
DE1792271C3 (de) Blutdrucksenkendes Arzneimittel
DE2823267C2 (xx)
DE1963223A1 (de) Mittel zur Behandlung von Virusinfektionen
DE4217396A1 (de) Metrifonat enthaltendes Arzneimittel
DE2532180C2 (de) Verwendung von Etozolin bei der Bekämpfung der Hypertonie
DE2810051A1 (de) Zubereitung fuer die behandlung von asthma
DE1806400A1 (de) Pharmazeutisches Produkt,insbesondere injizierbares Lakalanaesthetikum
DE2254018A1 (de) Neue pharmazeutische praeparate
DE2109657C3 (de) DL-m-Tyrosinester und L-m-Tyrosinester, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3006575A1 (de) Mittel zur behandlung der fettleibigkeit
DE2055813A1 (de) Therapeutisch wirksames Mittel
DE2004281C3 (de) Vasodilatatorisches Mittel

Legal Events

Date Code Title Description
OHA Expiration of time for request for examination